Fine epitope mapping of humanized anti-IgE monoclonal antibody omalizumab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Fine epitope mapping of humanized anti-IgE monoclonal antibody omalizumab

Published:2008-10 Issue:4 Volume:375 Page:619-622
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Zheng Lei,Li Bohua,Qian Weizhu,Zhao Lei,Cao Zhiguo,Shi Shu,Gao Jie,Zhang Dapeng,Hou Sheng,Dai Jianxin,Wang Hao,Guo Yajun

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference17 articles.

1. Epidemiology of rhinitis and asthma;Lundbäck;Clin. Exp. Allergy,1998

2. The pharmacological basis of anti-IgE therapy;Chang;Nat. Biotechnol.,2000

3. The receptor with high affinity for immunoglobulin E;Metzger;Annu. Rev. Immunol.,1986

4. Can anti-IgE be used to treat allergy?;Davis;Springer Semin. Immunopathol.,1993

5. Structure of the Fc fragment of human IgE bound to its high-affinity receptor Fc epsilonRI alpha;Garman;Nature,2000

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioequivalence Between a New Omalizumab Prefilled Syringe With an Autoinjector or with a Needle Safety Device Compared with the Current Prefilled Syringe: A Randomized Controlled Trial in Healthy Volunteers;Clinical Pharmacology in Drug Development;2024-02-22

2. Therapeutic tactics for targeting B lymphocytes in autoimmunity and cancer;European Journal of Immunology;2023-10-20

3. Ligelizumab impairs IgE ‐binding to plasmacytoid dendritic cells more potently than omalizumab and restores IFN ‐α production and FOXP3 ⁺ Treg generation;Allergy;2022-11-12

4. Development and characterization of a unique anti‐IgE mouse monoclonal antibody cross‐reactive between human and canine IgE;Immunity, Inflammation and Disease;2021-09-17

5. Determinants of omalizumab dose–related efficacy in oral immunotherapy: Evidence from a cohort of 181 patients;Journal of Allergy and Clinical Immunology;2021-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3